4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-022204
CEO and Chairman sold 15,000 shares at an average $42.89 ($643,416)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-17 | Sale : show line 1 in the form | −1,901 | $43.22 | $82,161 | 1,776,560 | D |
| 2021-03-17 | Sale : show line 2 in the form | −1,295 | $44.03 | $57,019 | 1,775,265 | D |
| 2021-03-17 | Sale : show line 3 in the form | −1,804 | $45.25 | $81,631 | 1,773,461 | D |
| 2021-03-18 | Sale : show line 4 in the form | −1,926 | $41.90 | $80,699 | 1,771,535 | D |
| 2021-03-18 | Sale : show line 5 in the form | −2,604 | $42.81 | $111,477 | 1,768,931 | D |
| 2021-03-18 | Sale : show line 6 in the form | −470 | $43.78 | $20,577 | 1,768,461 | D |
| 2021-03-19 | Sale : show line 7 in the form | −4,900 | $41.96 | $205,604 | 1,763,561 | D |
| 2021-03-19 | Sale : show line 8 in the form | −100 | $42.48 | $4,248 | 1,763,461 | D |
| Open-market sales · 15,000 sh · avg $42.89 · $643,416 | ||||||
Loading xslF345X03/doc4.xml…